The Landmark Series: Randomized Control Trials Examining Perioperative Chemotherapy and Postoperative Adjuvant Chemotherapy for Resectable Colorectal Liver Metastasis
- 14 August 2020
- journal article
- review article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 27 (11) , 4263-4270
Abstract
Surgical resection remains the only curative treatment option for patients with colorectal liver metastases (CLM). However, the high recurrence rate afterKeywords
Funding Information
- Foundation for the National Institutes of Health (T32 CA 009599)
This publication has 38 references indexed in Scilit:
- RAS Mutation Status Predicts Survival and Patterns of Recurrence in Patients Undergoing Hepatectomy for Colorectal Liver MetastasesAnnals of Surgery, 2013
- Comprehensive molecular characterization of human colon and rectal cancerNature, 2012
- Cetuximab Plus Irinotecan, Fluorouracil, and Leucovorin As First-Line Treatment for Metastatic Colorectal Cancer: Updated Analysis of Overall Survival According to Tumor KRAS and BRAF Mutation StatusJournal of Clinical Oncology, 2011
- High Survival Rate After Two-Stage Resection of Advanced Colorectal Liver Metastases: Response-Based Selection and Complete Resection Define OutcomeJournal of Clinical Oncology, 2011
- Effect on Outcome of Recurrence Patterns After Hepatectomy for Colorectal MetastasesAnnals of Surgical Oncology, 2010
- KRAS Mutation Correlates With Accelerated Metastatic Progression in Patients With Colorectal Liver MetastasesAnnals of Surgical Oncology, 2009
- Postoperative Surveillance Recommendations for Early Stage Colon Cancer Based on Results From the Clinical Outcomes of Surgical Therapy TrialJournal of Clinical Oncology, 2009
- A randomized phase III study comparing adjuvant 5-fluorouracil/folinic acid with FOLFIRI in patients following complete resection of liver metastases from colorectal cancerAnnals of Oncology, 2009
- Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trialThe Lancet, 2008
- Recurrence and Outcomes Following Hepatic Resection, Radiofrequency Ablation, and Combined Resection/Ablation for Colorectal Liver MetastasesAnnals of Surgery, 2004